GARDEN CITY, NY - Beyond Air, Inc. (NASDAQ:XAIR), a medical device company specializing in the design and development of therapeutic products, has entered into a sales agreement to potentially sell up ...
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a pharmaceutical company with a market capitalization of $72.6 million, has ...
LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced the closing of its previously announced registered ...
The shares of common stock of the Company are expected to begin trading on the Nasdaq Capital Market on February 12, 2025, under the ticker symbol “AGH.” The Offering is expected to close on February ...
Hyperfine, Inc. (Nasdaq: HYPR) ("Hyperfine" or the "Company") today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company’s ...
Detailed price information for Gd Culture Group Ltd (GDC-Q) from The Globe and Mail including charting and trades.
The Fund returned 1.77% and the J.P. Morgan CLO AAA Index returned 1.59%. Click here to read the full commentary.
FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (“Fobi” or the “Company”) announces that it has applied to its principal regulator, the British Columbia Securities Commission (“BCSC”), for a variation order ...
1d
Aptose Biosciences Inc. (“Aptose” or the“Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback